Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A multicenter, open-label, randomized, proof-of-concept phase II clinical trial to assess the efficacy and safety of icatibant in patients infected with SARS-CoV-2 (COVID-19) and admitted to hospital units without invasive mechanical ventilation: study protocol (ICAT-COVID).
Malchair P, Otero A, Giol J, Solanich X, Carnaval T, Fernández-Nistal A, Sánchez-Gabriel A, Montoto C, Lleonart R, Videla S; ICAT-COVID team. Malchair P, et al. Trials. 2022 Apr 12;23(1):303. doi: 10.1186/s13063-022-06219-7. Trials. 2022. PMID: 35413921 Free PMC article.
High-titre methylene blue-treated convalescent plasma as an early treatment for outpatients with COVID-19: a randomised, placebo-controlled trial.
Alemany A, Millat-Martinez P, Corbacho-Monné M, Malchair P, Ouchi D, Ruiz-Comellas A, Ramírez-Morros A, Rodríguez Codina J, Amado Simon R, Videla S, Costes G, Capdevila-Jáuregui M, Torrano-Soler P, San José A, Bonet Papell G, Puig J, Otero A, Ruibal Suarez JC, Zarauza Pellejero A, Llopis Roca F, Rodriguez Cortez O, Garcia Garcia V, Vidal-Alaball J, Millan A, Contreras E, Grifols JR, Ancochea À, Galvan-Femenia I, Piccolo Ferreira F, Bonet M, Cantoni J, Prat N, Ara J, Forcada Arcarons A, Farré M, Pradenas E, Blanco J, Àngel Rodriguez-Arias M, Fernández Rivas G, Marks M, Bassat Q, Blanco I, Baro B, Clotet B, Mitjà O; CONV-ERT Group. Alemany A, et al. Among authors: malchair p. Lancet Respir Med. 2022 Mar;10(3):278-288. doi: 10.1016/S2213-2600(21)00545-2. Epub 2022 Feb 9. Lancet Respir Med. 2022. PMID: 35150610 Free PMC article. Clinical Trial.
Exceptional treatment of COVID-19 pneumonia with icatibant.
Giol J, Jacob J, Llopis F, Lleonart R, Ruiz Esteve F, Malchair P. Giol J, et al. Among authors: malchair p. Emergencias. 2022 Apr;34(2):159-160. Emergencias. 2022. PMID: 35275476 Free article. English, Spanish. No abstract available.
Prospective individual patient data meta-analysis of two randomized trials on convalescent plasma for COVID-19 outpatients.
Millat-Martinez P, Gharbharan A, Alemany A, Rokx C, Geurtsvankessel C, Papageorgiou G, van Geloven N, Jordans C, Groeneveld G, Swaneveld F, van der Schoot E, Corbacho-Monné M, Ouchi D, Piccolo Ferreira F, Malchair P, Videla S, García García V, Ruiz-Comellas A, Ramírez-Morros A, Rodriguez Codina J, Amado Simon R, Grifols JR, Blanco J, Blanco I, Ara J, Bassat Q, Clotet B, Baro B, Troxel A, Zwaginga JJ, Mitjà O, Rijnders BJA; CoV-Early study group; COnV-ert study group. Millat-Martinez P, et al. Among authors: malchair p. Nat Commun. 2022 May 11;13(1):2583. doi: 10.1038/s41467-022-29911-3. Nat Commun. 2022. PMID: 35546145 Free PMC article.
[Revisit after discharge from the emergency department in a cohort of patients with COVID-19 pneumonia and analysis based on the healthcare resource used for follow-up. RESALSEVID study].
Albert A, Llorens P, Aguirre A, Martín-Sánchez FJ, Mínguez S, Moreno O, Ferré C, Valls A, Espinosa B, Murillo O, Cirera I, Gil A, Rivera S, Llopis F, Malchair P, Gonzalez Del Castillo J, Jacob J; en representación del grupo de investigadores del estudio RESALSEVID. Albert A, et al. Among authors: malchair p. J Healthc Qual Res. 2023 Jan-Feb;38(1):26-34. doi: 10.1016/j.jhqr.2022.05.007. Epub 2022 Jun 8. J Healthc Qual Res. 2023. PMID: 35739038 Free PMC article. Spanish.
Three-Day Icatibant on Top of Standard Care in Patients With Coronavirus Disease 2019 Pneumonia: A Randomized, Open-Label, Phase 2, Proof-of-Concept Trial.
Malchair P, Giol J, García V, Rodríguez O, Ruibal JC, Zarauza A, Llopis F, Matellán L, Bernal T, Solís B, Otero A, Carnaval T, Jofre H, Jacob J, Solanich X, Antolí A, Rocamora G, Videla S. Malchair P, et al. Clin Infect Dis. 2023 May 24;76(10):1784-1792. doi: 10.1093/cid/ciac984. Clin Infect Dis. 2023. PMID: 36610464 Free PMC article. Clinical Trial.
Bayesian Analysis of the ICAT·COVID Randomized Clinical Trial.
Malchair P, Villoria J, Giol J, Jacob J, Carnaval T, Videla S. Malchair P, et al. Clin Ther. 2024 Feb;46(2):176-180. doi: 10.1016/j.clinthera.2023.11.010. Epub 2023 Dec 10. Clin Ther. 2024. PMID: 38072752 Free article. Clinical Trial. No abstract available.
Author Correction: Prospective individual patient data meta-analysis of two randomized trials on convalescent plasma for COVID-19 outpatients.
Millat-Martinez P, Gharbharan A, Alemany A, Rokx C, Geurtsvankessel C, Papageorgiou G, van Geloven N, Jordans C, Groeneveld G, Swaneveld F, van der Schoot E, Corbacho-Monné M, Ouchi D, Piccolo Ferreira F, Malchair P, Videla S, García García V, Ruiz-Comellas A, Ramírez-Morros A, Rodriguez Codina J, Amado Simon R, Grifols JR, Blanco J, Blanco I, Ara J, Bassat Q, Clotet B, Baro B, Troxel A, Zwaginga JJ, Mitjà O, Rijnders BJA; CoV-Early study group; COnV-ert study group. Millat-Martinez P, et al. Among authors: malchair p. Nat Commun. 2024 May 22;15(1):4352. doi: 10.1038/s41467-024-48645-y. Nat Commun. 2024. PMID: 38778041 Free PMC article. No abstract available.
The patient's experience: a new view of the emergency department?
Guillén García L, Chamorro Martín FJ, Martín Tarapiella C, Malchair P. Guillén García L, et al. Among authors: malchair p. Emergencias. 2023 Dec;35(6):468-470. doi: 10.55633/s3me/E013.2023. Emergencias. 2023. PMID: 38116973 Free article. English, Spanish. No abstract available.
15 results